National Cancer Statistics in Korea, 2014

National Cancer Statistics in Korea, 2014 2016. 12. 20. Korea Central Cancer Registry

Cancer Incidence in Korea, 2014

National Cancer Incidence, 2014

Trends in Cancer Incidence by Sex and Year * Dark colored bars represent thyroid cancer incident cases

Comparison of cancer cases and rates between 2013 and 2014

Number of cases by cancer sites (2013-2014)

Distribution by Cancer Sites, 2014

Distribution by Cancer Sites and Sex, 2014

Trends in Age-standardized Incidence Rate: All Cancer Sites, 1999-2014 Trend1 Trend2 Sex Period APC (%) Period APC (%) Both sexes 1999-2012 3.6* 2012-2014 -6.5* Male 1999-2011 1.8* 2011-2014 -3.4* Female 1999-2012 5.8* 2012-2014 -7.9* * P < 0.05 * Age-standardized incidence Rate (ASR) was standardized to the Korean standard population (year 2000)

Trends in Age-standardized Incidence Rate: Excluding Thyroid, 1999-2014 Trend1 Trend2 sex Period APC (%) Period APC (%) Both Sexes 1999-2011 1.7* 2011-2014 -2.5* Male 1999-2011 1.1* 2011-2014 -3.8* Female 1999-2011 2.2* 2011-2014 -1.0 * P < 0.05 * Age-standardized incidence Rate (ASR) was standardized to the Korean standard population (year 2000)

Trends in Major Cancers 1) : Both Sexes, 1999-2014 Cancer sites Period Trend 1 Trend 2 APC (%) Period APC (%) Thyroid 1999-2011 22.7* 2011-2014 -10.4* Stomach 1999-2011 -0.1 2011-2014 -5.8* Colon and rectum 1999-2011 5.4* 2011-2014 -7.4* Lung 1999-2011 0.1 2011-2014 -1.7* Breast 1999-2005 7.3* 2005-2014 4.4* Liver 1999-2010 -1.7* 2010-2014 -4.3* Prostate 1999-2009 14.9* 2009-2014 0.7 1) Major sites selected based on 2014 crude rates * Age-standardized incidence Rate (ASR) was standardized to the Korean standard population (year 2000) * P < 0.05

Trends in Major Cancers 1) : Male, 1999-2014 Cancer sites Period Trend 1 Trend 2 APC (%) Period APC (%) Stomach 1999-2011 -0.4* 2011-2014 -6.3* Lung 1999-2005 0.0 2005-2014 -1.5* Colon and rectum 1999-2011 5.8* 2011-2014 -8.1* Liver 1999-2009 -1.9* 2009-2014 -3.9* Prostate 1999-2009 13.4* 2009-2014 -0.2 Thyroid 1999-2012 23.6* 2012-2014 -16.4* 1) Major sites selected based on 2014 crude rates * Age-standardized incidence Rate (ASR) was standardized to the Korean standard population (year 2000) * P < 0.05

Trends in Major Cancers 1) : Female, 1999-2014 Cancer sites Period Trend 1 Trend 2 APC (%) Period APC (%) Thyroid 1999-2011 22.3* 2011-2014 -11.7* Breast 1999-2005 7.5* 2005-2014 4.5* Colon and rectum 1999-2011 4.5* 2011-2014 -6.5* Stomach 1999-2011 -0.3 2011-2014 -5.4* Lung 1999-2011 1.9* 2011-2014 -0.5 Cervix uteri 1999-2014 -3.7* 1) Major sites selected based on 2014 crude rates * Age-standardized incidence Rate (ASR) was standardized to the Korean standard population (year 2000) Liver 1999-2011 -1.4* 2011-2014 -6.0* * P < 0.05

Cumulative Risk of Cancer in Korea, 2014 Male 38.7% (79 years*) (2 out of 5) Female 33.1% (85 years*) (1 out of 3) * Life Expectancy, 2014 (Source : Statistics Korea )

International Comparison of Age-Standardized Incidence Rates 1) by Sex 1) The incidence rates of all cancers excluding non-melanoma skin cancer(c44) are age-adjusted using the world standard population to compare globally 2) Estimated cancer incidence rate for 2012 using the cancer registration data by the year 2007 (GLOBOCAN 2012, IARC, 2013) 3) Korea: Cancer Incidence data, 2014 (Published in 2016)

International Comparison of Age-Standardized Incidence Rates: Male Rank * Korea 1) (2014) Estimated rates (2012) 2) (Unit: rate per 100,000) Japan USA UK All Cancers 297.1 All Cancers 260.4 All Cancers 347.0 All Cancers 284.0 Excluding Thyroid 279.8 Excluding Thyroid 258.2 Excluding Thyroid 340.6 Excluding Thyroid 282.5 1 Stomach 52.7 Stomach 45.7 Prostate 98.2 Prostate 73.2 2 Lung 43.7 Colon and rectum 42.1 Lung 44.2 Colon and rectum 36.8 3 Colon and rectum 42.6 Lung 38.8 Colon and rectum 28.5 Lung 34.9 4 Lung 31.4 Prostate 30.4 Bladder 19.6 Melanoma of skin 13.7 5 Liver 25.6 Liver 14.6 Melanoma of skin 16.8 Non-Hodgkin Lymphoma 11.9 6 Prostate 17.3 Esophagus 11.1 Kidney 15.9 Kidney 10.9 7 Thyroid 8.4 Pancreas 10.6 Non-Hodgkin Lymphoma 14.7 Esophagus 10.0 8 Pancreas 8.4 Bladder 9.8 Leukemia 10.3 Leukemia 9.3 9 Kidney 8.4 Non-Hodgkin Lymphoma 7.9 Liver 9.8 Bladder 9.2 10 Non-Hodgkin Lymphoma 8.1 Kidney 7.8 Pancreas 8.6 Pancreas 6.8 1) The incidence rates of all cancers excluding non-melanoma skin cancer(c44) are age-adjusted using the world standard population to compare globally 2) Estimated cancer incidence rate for 2012 using the cancer registration data by the year 2007 (GLOBOCAN 2012, IARC, 2013) * Ranked by the order of age-standardized rates

International Comparison of Age-Standardized Incidence Rates: Female Rank * Korea 1) (2014) Estimated rates (2012) 2) Japan USA UK All Cancers 250.5 All Cancers 185.7 All Cancers 297.4 All Cancers 267.3 Excluding Thyroid 180.7 Excluding Thyroid 179.2 Excluding Thyroid 277.4 Excluding Thyroid 262.4 1 Thyroid 69.8 Breast 51.5 Breast 92.9 Breast 95.0 2 Breast 47.7 Colon and rectum 23.5 Lung 33.7 Lung 25.8 3 Colon and rectum 23.0 Stomach 16.5 Colon and rectum 22.0 Colon and rectum 24.4 4 Stomach 21.4 Lung 12.9 Thyroid 20.0 Melanoma of skin 15.6 5 Lung 14.9 Cervix uteri 10.9 Corpus uteri 19.5 Corpus uteri 13.9 6 Cervix uteri 9.0 Corpus uteri 10.6 Melanoma of skin 12.6 Ovary 11.7 7 Liver 8.6 Ovary 8.4 Non-Hodgkin 10.2 Non-Hodgkin 8.5 Lymphoma Lymphoma 8 Ovary 6.4 Pancreas 6.7 Kidney 8.5 Cervix uteri 7.1 9 Non-Hodgkin Lymphoma 10 Corpus uteri 5.7 5.7 Thyroid 6.5 Ovary 8.0 Leukemia 5.8 Non-Hodgkin Lymphoma (Unit: rate per 100,000) 5.9 Leukemia 7.1 Kidney 5.8 1) The incidence rates of all cancers excluding non-melanoma skin cancer(c44) are age-adjusted using the world standard population to compare globally 2) Estimated cancer incidence rate for 2012 using the cancer registration data by the year 2007 (GLOBOCAN 2012, IARC, 2013) * Ranked by the order of age-standardized rates

Cancer Survival in Korea, 2014 Subjects: 2,813,643 cancer cases diagnosed between January 1, 1993 and December 31, 2014 Follow-up: Through December 31, 2015

Trends in Five-Year Relative Survival by Sex: All cancers

Trends in Five-Year Relative Survival by Sex: Excluding Thyroid

Five-Year Survival of Major Cancer Sites 1) : Both sexes 1) Major sites selected based on 2014 crude rates * difference in the cancer survival probability between '93~'95 and 10~'14

Five-Year Survival of Major Cancer Sites 1) : Male 1) Major sites selected based on 2014 crude rates * difference in the cancer survival probability between '93~'95 and 10~'14

Five-Year Survival of Major Cancer Sites 1) : Female 1) Major sites selected based on 2014 crude rates * difference in the cancer survival probability between '93~'95 and 10~'14

Cancer Sites International Comparison of Five-Year Relative Survival Korea ( 96-00) Korea ( 01-05) Korea ( 10-14) USA 1) ( 06-12) Canada 2) ( 06-08) (Unit: %) Japan 3) ( 06-08) All cancers 44.0 53.9 70.3 69.0 60 62.1 Thyroid 94.9 98.3 100.2 98.3 98 93.7 Stomach 46.6 57.7 74.4 31.1 25 64.6 Colon and rectum 58.0 66.6 76.3 66.2 64 71.1 Lung 12.7 16.2 25.1 18.7 17 31.9 Breast 83.2 88.5 92.0 90.8 87 91.1 Liver 13.2 20.2 32.8 18.1 19 32.6 Prostate 67.2 80.3 93.3 99.3 95 97.5 Pancreas 7.6 8.2 10.1 8.5 8 7.7 Cervix uteri 80.0 81.3 79.7 68.8 73 73.4 1) Howlader N, et al. SEER Cancer Statistics Review, 1975-2013, National Cancer Institute. Bethesda, MD, http://seer.cancer.gov/csr/1975_2013/, based on November 2015 SEER data submission, posted to the SEER web site, April 2016 2) Canadian Cancer Society, Statistics Canada and Provincial/Territorial Cancer Registry. Canadian Cancer Statistics 2016 3) Center for Cancer Control and Information Services, National Cancer Center, Monitoring of Cancer Incidence in Japan - Survival 2006-2008 report 2016

Cancer Prevalence in Korea, 2014 Definition of cancer prevalence counts: - Cancer prevalence represents the people who are alive on January 1, 2015 among the patients who were diagnosed with cancer between January 1, 1999 and December 31, 2014 (limited-duration prevalence), which includes new and pre-existing cancer patients diagnosed during a given time period still alive on January 1, 2015. - Multiple primary cancer cases are counted multiple times.

Distribution of Cancer Prevalence, 2014

Distribution of Cancer Prevalence by Sex, 2014

Prevalence of All Cancers by Time since Diagnosis *, 2014 * People who are alive on January 1, 2015 among the cancer patients who were diagnosed between January 1, 1999 and December 31, 2014

Prevalence of the Major Cancer Sites by Time since Diagnosis, 2014 Time since diagnosis Thyroid Stomach Colon and rectum Breast Lung Prostate Liver Cervix uteri Kidney Non- Hodgkin lymphoma All cancers Under 1 year 30,635 26,812 24,674 18,144 16,808 9,526 11,491 3,331 4,141 4,283 189,119 1-2 years 42,457 24,241 22,870 16,888 10,208 8,858 8,162 3,187 3,713 3,621 174,156 2-5 years 120,630 65,813 61,623 43,990 17,890 21,992 17,409 9,158 9,307 8,782 443,505 More than 5 years 134,350 118,306 93,128 79,894 18,554 21,880 20,629 29,513 14,449 14,867 658,155 Total 328,072 235,172 202,295 158,916 63,460 62,256 57,691 45,189 31,610 31,553 1,464,935

Thank you